Posted Jan. 3, 2014 at 7:57 a.m.

Premium Lock Salix closes on $2.6B deal for San Diego pharma Santarus

Published: 2014-01-03 07:57:00
Updated: 2014-01-03 07:57:00

Salix Salix Image 1 of 2 · Next Image…

Salix, a specialty pharmaceutical company focused on gastrointestinal treatments, said it will acquire all of the outstanding common stock of Santarus at the price of $32 per share, a 37.9 premium over the company's Thursday closing price of $23.20...

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll